4 European Projects Found
Searched on 125080 European Projects
FINISHED
Combatting Bacterial Resistance in Europe (COMBACTE-NET)
Start date: Jan 1, 2013, End date: Dec 31, 2019,
The emergence of Antibiotic-resistant bacteria (ARB) is a global problem, having recently been elevated to the top three threats identified by the World Health Organisation (WHO), and subject of numerous national and international government activities, including the Trans-Atlantic Task Force on Antimicrobial Resistance established by the US and EU presidencies. The estimated costs of ARB are aro ...
Read Project
38
Partners Participants
FINISHED
PAtients Leading and mANaging their healThcare through EHealth (PALANTE)
Start date: Feb 1, 2012, End date: Jul 31, 2015,
Patient empowerment is considered a potential tool to reduce healthcare costs and improve efficiency of the health systems, reinforcing healthcare quality. Patient empowerment has become an element of high priority in the EU health strategy, supported by national and regional health authorities.Building on already existing e-health platforms and services in the participating regions, the PALANTE p ...
Read Project
21
Partners Participants
FINISHED
LINE-1 ACTIVITY IN SOMATIC STEM CELLS: IMPACT AND GENOMIC MOSAICISM (SOMATIC LINE-1)
Start date: Jun 24, 2008, End date: Jun 23, 2012,
"45% of the human genome is made of repeated DNA, and some types can be mobilized within the genome (mobile DNA). LINE-1 or L1 is the only autonomous active mobile DNA within the human genome, with 500.000 copies per haploid genome (~17% of the genome). Overall, L1 is responsible for ~30% of our genome. Due to its activity and number in the genome, the impact that L1 has and have on the genome is ...
Read Project
1
Partner Participant
FINISHED
Developmental Impact of MLL-AF4 Fusion Gene linked to Infant Acute Lymphoblastic Leukaemia on Human Stem Cell Fate (Leukaemogenesis)
End date: Sep 1, 2009,
The MLL gene is located in chromosome 11q23 and is implicated in >40 different chromosomal translocations, generating distinct leukaemic fusion genes. Unlike other MLL fusion proteins, t(4;11) MLL-AF4 is always found in infant pro-B-ALL with a dismal prognosis in infants and adults. In infant ALL where t(4;11) MLL-AF4 is very common (>80%), the gene fusion arises in utero. However, very litt ...
Read Project
